361 related articles for article (PubMed ID: 19366799)
1. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
3. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
4. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
[TBL] [Abstract][Full Text] [Related]
5. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.
Tzao C; Tung HJ; Jin JS; Sun GH; Hsu HS; Chen BH; Yu CP; Lee SC
Mod Pathol; 2009 Feb; 22(2):252-60. PubMed ID: 18953329
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities.
Zhang K; Li L; Zhu M; Wang G; Xie J; Zhao Y; Fan E; Xu L; Li E
J Proteomics; 2015 Jan; 112():180-9. PubMed ID: 25234497
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
[TBL] [Abstract][Full Text] [Related]
9. Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
Wang B; Zhou M; Gan XL; Ren YX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
Int J Clin Oncol; 2023 Sep; 28(9):1147-1157. PubMed ID: 37428307
[TBL] [Abstract][Full Text] [Related]
10. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
[TBL] [Abstract][Full Text] [Related]
11. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
12. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
13. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.
Xiao CK; Ren Y; Chen Q; Yang Y; Tang L; Xu L; Ren Z
Epigenetics; 2024 Dec; 19(1):2343593. PubMed ID: 38643489
[TBL] [Abstract][Full Text] [Related]
14. Global levels of histone modifications predict prognosis in different cancers.
Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
[TBL] [Abstract][Full Text] [Related]
15. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
16. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation and histone post-translational modification stability in post-mortem brain tissue.
Jarmasz JS; Stirton H; Davie JR; Del Bigio MR
Clin Epigenetics; 2019 Jan; 11(1):5. PubMed ID: 30635019
[TBL] [Abstract][Full Text] [Related]
18. H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer.
Juliano CN; Izetti P; Pereira MP; Dos Santos AP; Bravosi CP; Abujamra AL; Prolla PA; Osvaldt AB; Edelweiss MI
Appl Immunohistochem Mol Morphol; 2016; 24(5):337-44. PubMed ID: 26067135
[TBL] [Abstract][Full Text] [Related]
19. Global histone modifications predict prognosis of resected non small-cell lung cancer.
Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
[TBL] [Abstract][Full Text] [Related]
20. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.
Li D; Bi FF; Cao JM; Cao C; Liu B; Yang Q
Mol Cancer; 2014 Feb; 13():26. PubMed ID: 24502362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
